to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Successes of newborn screening programs.
Newborn screening: new developments in a proven field.
Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress.
Integration of new genetic diseases into statewide newborn screening: New England experience.
Communications systems and their models: Massachusetts parent compliance with recommended specialty care after positive cystic fibrosis newborn screening result.
Spectrum of medium-chain acyl-CoA dehydrogenase deficiency detected by newborn screening.
Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency.
A near-miss: very long chain acyl-CoA dehydrogenase deficiency with normal primary markers in the initial well-timed newborn screening specimen.
Long-term follow-up to ensure quality care of individuals diagnosed with newborn screening conditions: early experience in New England.
Neonatal screening for inborn errors of metabolism using tandem mass spectrometry: experience of the pilot study in Andhra Pradesh, India.
Enhanced interpretation of newborn screening results without analyte cutoff values.
Newborn screening for hepatorenal tyrosinemia-I by tandem mass spectrometry using pooled samples: a four-year summary by the New England newborn screening program.
Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
Challenges in implementing a successful newborn cystic fibrosis screening program.
High-throughput multiplexed T-cell-receptor excision circle quantitative PCR assay with internal controls for detection of severe combined immunodeficiency in population-based newborn screening.
Identification of an infant with severe combined immunodeficiency by newborn screening.
Ten Years of Newborn Screening for Severe Combined Immunodeficiency (SCID) in Massachusetts.
Massachusetts' Findings from Statewide Newborn Screening for Spinal Muscular Atrophy.
Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening Specimens.